Certain populations to receive Paxlovid free through 2024, under new agreement
By
Kristen Fischer
Oct 17, 2023
Paxlovid, an oral drug that treats COVID-19, will begin to enter the commercial market starting next month. At the same time, the US federal government is making sure that the country has enough supply,...
Study: When community-onset SARS-CoV-2 went up, so did cases that started in hospitals
By
Kristen Fischer
Aug 29, 2023
Rates of people contracting SARS-CoV-2 in the hospital were similar to other hospital-acquired infections. But when the number of infections that began in the community was higher, there was an increase...
Report: COVID-19 linked to higher dementia risk in older adults
By
Kristen Fischer
Feb 12, 2024
A new study found a link between having COVID-19 and a higher risk for dementia in people over the age of 60.
Older adults, immunocompromised net biggest benefits from COVID-19 boosters, model shows
By
Kristen Fischer
Mar 07, 2024
A new model estimates that people over 65 or those who are immunocompromised benefit the most from COVID-19 booster shots.
60 Seconds with … Jasmine Travers, PhD, RN
By
Kimberly Marselas
Oct 10, 2023
You recently studied the impact of the COVID-era Paycheck Protection Program, or PPP, on nursing homes. What did you find?
Balancing act: Dementia care needs to change for safe integration
By
Josh Henreckson
Apr 12, 2024
The quality of life tradeoffs incurred due to tight safety protocols and isolation of nursing home residents during the COVID-19 pandemic demand more research and policy changes.
New COVID vaccine threats emerge as mandate ends
By
Kimberly Marselas
Sep 11, 2023
The end of the nationwide healthcare worker requirement came as good news to many who saw it as an obstacle to hiring. Yet experts warned that the federal change could lead to new and potentially costly...